Quantcast

Latest Biologic Stories

2015-03-19 12:29:35

DALLAS, March 19, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "PharmaPoint: Rheumatoid Arthritis - US and 5EU Drug Forecast and Market Analysis to 2023" report provides

2015-03-19 08:27:19

SOUTH SAN FRANCISCO, Calif., March 19, 2015 /PRNewswire/ -- CytomX, a biotechnology company developing Probody(TM) therapeutics for the treatment of cancer, today announced the appointment of

2015-03-18 23:07:43

In the wake of the Food and Drug Administration’s first approval for a biosimilar product, pharma industry experts offer advice on how payers can prepare for this new class of drugs in the March

2015-03-17 16:26:27

Pivotal Results Comparing Brodalumab With Stelara® (Ustekinumab) and Placebo to be Presented in Late-Breaking Session THOUSAND OAKS, Calif., March 17, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN)

2015-03-16 12:27:20

CE Class Focuses on Fundamentals of Biosimilars EAST ELMHURST, N.Y., March 16, 2015 /PRNewswire/ -- With the U.S.

2015-03-13 08:26:21

If authorized, SB2 will be marketed in Europe by Biogen Idec INCHEON, South Korea, March 13, 2015 /PRNewswire/ -- Samsung Bioepis Co., Ltd., today announced that the Marketing Authorization

2015-03-11 23:04:25

According to the new report from BCC Research, the global biosimilars market was valued at $1.8 billion in 2013 and nearly $2.0 billion in 2014.

2015-03-10 08:35:43

SAN DIEGO, March 10, 2015 /PRNewswire/ -- Halozyme Therapeutics, Inc.


Word of the Day
meacock
  • An uxorious, effeminate, or spiritless man.
  • A timorous, cowardly fellow.
Probably a blend of meek and cock, or from meek +‎ -ock (“diminutive suffix”).